… systemic therapy in the treatment of breast cancer patients is … information in assessing
response to therapy as a complement to … therapy response for patients with primary breast cancer. …

… response to primary chemotherapy in breast cancer. However, there is no single definition
of a histopathologic response, and response … , a pathologic complete response is defined by …

… predicted a pathological complete response in an external validation cohort (75 patients)
with an area under the curve of 0.87. In conclusion, response to therapy is determined by the …

… Despite advances in detection and therapies, breast cancer is still the leading cause of cancer
… the signature of different cancers and in predicting outcome and response to therapies. …

… which cancer patients will benefit from specific therapies. In … breast cancer samples taken
before and during therapy to … -gene signature that predicts clinical response to AIs. We have …

… treatment response prediction and biomarkers for individualization of breast cancer therapy
… Monitoring treatment response by comparing before treatment and on-treatment blood and …

… breast cancer substantially decreases the risk of death. Patients often have de novo resistance
or incomplete response … the primary breast cancer can predict the response to docetaxel. …

… to chemotherapeutics, antiestrogens, and therapeutic anti-… marker of response to breast
cancer therapy and discuss the … response to chemotherapeutics and antiestrogens in breast …

… PET for therapy responses assessment in breast cancer is … FDG PET in predicting responses
to neoadjuvant therapies with meta-… To predict histopathological response in primary breast …

… Interestingly, a study has evaluated the prognostic role of gene expression modules
related to key biologic processes in breast cancer. In this analysis, the immune response-related …